Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice

Eli Lilly and Company1 site in 1 country518 target enrollmentNovember 2007

ConditionsADHD

InterventionsAtomoxetine stimulants (any approved ADHD medication)

DrugsAtomoxetine stimulants (any approved ADHD medication)

Overview

Phase: Not Applicable
Intervention: Atomoxetine
Conditions: ADHD
Sponsor: Eli Lilly and Company
Enrollment: 518
Locations: 1
Status: Completed
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

The primary research objective of this observational study is to evaluate treatment compliance over one year in children and adolescents who are newly initiated on medication approved for the treatment of ADHD in a routine clinical setting. Compliance will be assessed using the Pediatric Compliance Self-Rating (PCSR) Instrument. A patient will be considered as compliant at a given visit, if the PCSR score is at least 5, corresponding to taking the medication at least often.

Registry

clinicaltrials.gov

Start Date

November 2007

End Date

June 2009

Last Updated

16 years ago

Study Type

Observational

Sex

All